Our ‘bench to bedside’ research is saving lives
Read more about our world-leading 'bench to bedside' research cycle, and how you can support it this tax-time, so we can ultimately save ALL lives from melanoma.
Read more about our world-leading 'bench to bedside' research cycle, and how you can support it this tax-time, so we can ultimately save ALL lives from melanoma.
We recognise our incredible community of fundraisers who continue to amaze us with their courage and creativity. From comedy nights and golf days to marathons, music gigs, Facebook fundraisers and more – they've found unique ways to make a difference.
Three studies led by researchers at Melanoma Institute Australia (MIA) are paving the way for less surgical and drug intervention for early stage melanoma patients.
Guests at this year’s Amie St Clair Ball in Wagga Wagga will be welcomed to a ‘Night at the Carnival’ themed evening.
Read more about the amazing initiatives organised by our wonderful community, which not only raise critical funds for research, but also generate life-saving awareness.
The NHMRC grant will enable MIA to lead an international clinical trial aiming to safely reduce surgery for high risk Stage III melanoma patients who have had a good response to neoadjuvant immunotherapy.
A study has been released investigating the effectiveness of a Melanoma Care Program for patients with early-stage melanoma with varying degrees of fear of cancer recurrence after treatment of their primary melanoma.
The extensive global use of MIA’s online tool for estimating the risk of nodal metastasis in newly diagnosed melanoma patients has prompted an international study to validate its accuracy & improve its precision across diverse populations worldwide.
MIA researchers and clinicians attended the World Congress of Melanoma, held in conjunction with the EADO Congress, in Athens.
See all the photos from our Melanoma March 2025 events, and download yours.